{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:42:48Z","timestamp":1793421768070,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1245\/s10434-015-4758-y","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T12:18:54Z","timestamp":1439209134000},"page":"3208-3212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon"],"prefix":"10.1245","volume":"22","author":[{"given":"Peter","family":"Angelos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bedrosian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Euhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia M.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,11]]},"reference":[{"key":"4758_CR1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2012.43.2013","volume":"31","author":"AS Reiner","year":"2013","unstructured":"Reiner AS, John EM, Brooks JD, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women\u2019s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol. 2013;31:433\u20139.","journal-title":"J Clin Oncol"},{"key":"4758_CR2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher B, Costantino J, Redmond C, Poisson R, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989;320:479\u201384.","journal-title":"N Engl J Med"},{"key":"4758_CR3","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/bjc.2011.120","volume":"104","author":"K Metcalfe","year":"2011","unstructured":"Metcalfe K, Gershman S, Lynch, HT. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2011;104:1384\u201392.","journal-title":"Br J Cancer"},{"key":"4758_CR4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","volume":"9","author":"JF Forbes","year":"2008","unstructured":"Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008;9:45\u201353.","journal-title":"Lancet Oncol"},{"key":"4758_CR5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2010.32.7395","volume":"29","author":"HB Nichols","year":"2011","unstructured":"Nichols HB, Berrington de Gonzalez A, Lacey JV Jr, Rosenberg PS, Anderson WF. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. 2011;29:1564\u20139.","journal-title":"J Clin Oncol"},{"key":"4758_CR6","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1200\/JCO.2008.19.9430","volume":"27","author":"MK Graeser","year":"2009","unstructured":"Graeser MK, Engel C, Rhiem K. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2009;27:5887\u201392.","journal-title":"J Clin Oncol"},{"key":"4758_CR7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/djq018","volume":"102","author":"I Bedrosian","year":"2010","unstructured":"Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102:401\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"4758_CR8","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1002\/cncr.27574","volume":"118","author":"AM Brewster","year":"2012","unstructured":"Brewster AM, Bedrosian I, Parker PA, et al. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer. 2012;118:5637\u201343.","journal-title":"Cancer"},{"key":"4758_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju160","volume":"106","author":"PR Portschy","year":"2014","unstructured":"Portschy PR, Kuntz KM, Tuttle TM. Survival outcomes after contralateral prophylactic mastectomy: a decision analysis. J Natl Cancer Inst. 2014;106:1\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"4758_CR10","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2005.10.080","volume":"23","author":"LJ Herrinton","year":"2005","unstructured":"Herrinton LJ, Barlow WE, Yu O, et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005;23:4275\u201386.","journal-title":"J Clin Oncol"},{"key":"4758_CR11","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","volume":"27","author":"TM Tuttle","year":"2009","unstructured":"Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362\u20137.","journal-title":"J Clin Oncol"},{"key":"4758_CR12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamasurg.2013.5689","volume":"149","author":"ST Hawley","year":"2014","unstructured":"Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ, Katz SJ. Social and clinical determinants of contralateral prophylactic mastectomy. JAMA Surg. 2014;149:582\u20139.","journal-title":"JAMA Surg"},{"key":"4758_CR13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jama.2013.101055","volume":"310","author":"SJ Katz","year":"2013","unstructured":"Katz SJ, Morrow M. Contralateral prophylactic mastectomy for breast cancer: addressing peace of mind. JAMA. 2013;310:793\u20134.","journal-title":"JAMA"},{"key":"4758_CR14","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1475-6773.2008.00843.x","volume":"43","author":"ST Hawley","year":"2008","unstructured":"Hawley ST, Fagerlin A, Janz NK, Katz SJ. Racial\/ethnic differences in knowledge about the risks and benefits of breast cancer treatment: does it matter where you go? Health Serv Res. 2008;43:1366\u201387.","journal-title":"Health Serv Res"},{"key":"4758_CR15","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1002\/cncr.28260","volume":"119","author":"SJ Katz","year":"2013","unstructured":"Katz SJ, Morrow M. Addressing overtreatment in breast cancer: the doctors\u2019 dilemma. Cancer. 2013;119:3584\u20138.","journal-title":"Cancer"},{"key":"4758_CR16","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jama.1961.03040130004002","volume":"175","author":"D Oken","year":"1961","unstructured":"Oken D. What to tell cancer patients: a study of medical attitudes. JAMA. 1961;175:1120\u20138.","journal-title":"JAMA."},{"key":"4758_CR17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jama.1979.03290350017012","volume":"241","author":"DH Novack","year":"1979","unstructured":"Novack DH, Plumer R, Smith RL, Ochitill H, Morrow GR, Bennett JM. Changes in physicians\u2019 attitudes toward telling the cancer patient. JAMA. 1979;241:897\u2013900.","journal-title":"JAMA"},{"key":"4758_CR18","doi-asserted-by":"crossref","unstructured":"Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015; 121:25\u201333. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25186627 .","DOI":"10.1002\/cncr.29010"},{"key":"4758_CR19","doi-asserted-by":"crossref","unstructured":"LaDuca H, Stuenkel AJ, Dolinsky JS, et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2000 patients. Genet Med. 2014;16:830\u20137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24763289 .","DOI":"10.1038\/gim.2014.40"},{"key":"4758_CR20","unstructured":"National Comprehensive Cancer Network. Genetic\/familial high-risk assessment: breast and ovarian. In: NCCN clinical practice guidelines in oncology v12015. vol. 1. Fort Washington; 2015."},{"key":"4758_CR21","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","volume":"29","author":"C Cybulski","year":"2011","unstructured":"Cybulski C, Wokolorczyk D, Jakubowska A, et al. Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol. 2011;29:3747\u201352.","journal-title":"J Clin Oncol"},{"key":"4758_CR22","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/bcr2919","volume":"13","author":"DE Goldgar","year":"2011","unstructured":"Goldgar DE, Healey S, Dowty JG, et al. Rare variants in the ATM gene and risk of breast cancer. BCR Breast Cancer Res. 2011;13:R73.","journal-title":"BCR Breast Cancer Res"},{"key":"4758_CR23","doi-asserted-by":"crossref","unstructured":"Bogdanova N, Cybulski C, Bermisheva M, et al. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer. Breast Cancer Res Treat. 2009;118:207\u201311. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18807267 .","DOI":"10.1007\/s10549-008-0189-9"},{"key":"4758_CR24","first-page":"1","volume":"124","author":"ES Hu","year":"2009","unstructured":"Hu ES, Pusic AL, Waljee JF, Kuhn L, Hawley ST, Wilkins E, Alderman AK. Patient-reported aesthetic satisfaction with breast reconstruction during the long-term survivorship period. Plast Reconstr Surg. 2009;124:1\u20138.","journal-title":"Plast Reconstr Surg"},{"key":"4758_CR25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1245\/s10434-014-4246-9","volume":"22","author":"DM Atisha","year":"2015","unstructured":"Atisha DM, Rushing CN, Samsa GP, Locklear TD, Cox CE, Shelley Hwang E, Zenn MR, Pusic AL, Abernethy AP. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol. 2015;22:361\u20139.","journal-title":"Ann Surg Oncol"},{"key":"4758_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PRS.0b013e3182729cde","volume":"131","author":"CR Albornoz","year":"2013","unstructured":"Albornoz CR, Bach PB, Mehrara BJ, Disa JJ, Pusic AL, McCarthy CM, Cordeiro PG, Matros E. A paradigm shift in U.S. breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131:15\u201323.","journal-title":"Plast Reconstr Surg"},{"key":"4758_CR27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/PRS.0b013e31824a29c5","volume":"129","author":"CR Albornoz","year":"2012","unstructured":"Albornoz CR, Bach PB, Pusic AL, McCarthy CM, Mehrara BJ, Disa JJ, Cordeiro PG, Matros E. The influence of sociodemographic factors and hospital characteristics on the method of breast reconstruction, including microsurgery: a U.S. population-based study. Plast Reconstr Surg. 2012;129:1071\u20139.","journal-title":"Plast Reconstr Surg"},{"key":"4758_CR28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.amjsurg.2011.01.018","volume":"201","author":"E Han","year":"2011","unstructured":"Han E, Johnson N, Glissmeyer M, Wagie T, Carey B, DelaMelena T, Nelson J. Increasing incidence of bilateral mastectomies: the patient perspective. Am J Surg. 2011;201:615\u20138.","journal-title":"Am J Surg"},{"key":"4758_CR29","doi-asserted-by":"crossref","first-page":"320e","DOI":"10.1097\/PRS.0b013e31827cf576","volume":"131","author":"Y Cemal","year":"2013","unstructured":"Cemal Y, Albornoz CR, Disa JJ, McCarthy CM, Mehrara BJ, Pusic AL, Cordeiro PG, Matros E. A paradigm shift in U.S. breast reconstruction: part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg. 2013;131:320e\u20136e.","journal-title":"Plast Reconstr Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4758-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-015-4758-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4758-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:22:07Z","timestamp":1559632927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-015-4758-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,11]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["4758"],"URL":"https:\/\/doi.org\/10.1245\/s10434-015-4758-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,11]]}}}